CDH1 and gastric cancer: Screening and prevention programs offer an opportunity to reduce GC mortality, but only a minority of individuals (<1%) shows an identified germline gene defect (i.e., CDH1 gene mutation), for which intense surveillance or prophylactic gastrectomy are provided.